Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 61 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Pharma Zoute from Knokke-Heist, company number BE0871797297, closed financial year 2025 with a result of € -32,554 after tax. For that financial year Pharma Zoute recorded a gross margin of € 92,152 and equity of € 125,843. Compared with financial year 2024, the result moved from € -17,479 to € -32,554. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2026.
€ 125,843
▼ 21% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -32,554
▼ 86 % more loss than in 2024
Profit after tax over the fiscal year.
€ 335,209
▲ 9% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 107,243.
People and assets in 2025
1.1
▼ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 81,168
▲ 3% vs 2024
€ 73,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 9,911
▼ 33% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 48,664
▲ 14% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 29,720
▲ 8% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 119,894 | € 111,297 | € 107,943 | € 92,152 | ▼ 15% |
| Profit after taxes | € 16,079 | € -9,288 | € -17,479 | € -32,554 | ▼ € 15,075 |
| Equity | € 185,164 | € 175,876 | € 158,397 | € 125,843 | ▼ 21% |
| Total debts | € 595,416 | € 544,275 | € 568,607 | € 589,120 | ▲ 4% |
| Cash | € 302,487 | € 274,794 | € 308,004 | € 335,209 | ▲ 9% |
| Land & buildings | € 25,610 | € 19,207 | € 12,805 | € 6,403 | ▼ 50% |
| Retained profit | € 166,564 | € 157,276 | € 139,797 | € 107,243 | ▼ 23% |
| Balance sheet total | € 780,580 | € 720,151 | € 727,004 | € 714,962 | ▼ 2% |
| Employees (FTE) | 1.4 | 1.3 | 1.3 | 1.1 | ▼ 0.2 |
Key figures of Pharma Zoute, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Pharma Zoute?
What happened at Pharma Zoute in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 32,554. filed late Source: NBB ↗
- New establishment in Knokke-Heist. KBO
- New establishment in Knokke-Heist. KBO
- Start of the company according to the CBE. KBO
- Patrick Hoornaert became a director. NBB
- Evelien Vancraeynest became a director. NBB
In short
From € 16,079 profit in 2022 to € 32,554 loss in 2025.
Paid € 6,649 in corporate taxes since 2022.
Best year ever: 2022, with € 16,079 profit.
On average € 83,800 of value added per employee in 2025.
A new publication or filing at Pharma Zoute? We notify you, reason included.
Follow Pharma ZouteDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Pharma Zoute are Patrick Hoornaert and Evelien Vancraeynest. Patrick Hoornaert is also behind SOLITHERM, DEMACO INVEST, HOOCAF and HOOP.
Directors
According to the 2025 annual accounts
since 2005
Evelien Vancraeynest
Director
since 2005
Establishments
Establishment units
Physical locations of this company
Kalfduinen 2a
8300 Knokke-Heist
Kalfduinen 2 box a
8300 Knokke-Heist
Active since 9 February 2005
Dumortierlaan 110
8300 Knokke-Heist
Active since 31 October 2007
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
one.com Mail
Hosting
ONECOM, DK
Website info
Features
Security
Network
Details
- Company number
- 0871.797.297
- VAT number
- BE 0871.797.297
- Registered office
- Kalfduinen 2a, 8300 Knokke-Heist
- Names & denominations
- Pharma Zoute
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 February 2005
- Peppol
- Active · Active since 2 Dec 2025
- Contact
- pharmacieduzoute.be
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten